reductase deficiency with non-progressive encephalopathy. It is suggested that the detection of cytochrome b5 reductase activity in platelets, in addition to that in leucocytes, is useful for the assessment of a generalised enzyme defect. Genetical involvement of the present cases is discussed in association with the diaphorase gene loci in humans.
Hereditary methaemoglobinaemia is a recessive inborn error of metabolism which causes an increased methaemoglobin concentration in erythrocytes as a result of a deficiency in the ability to reduce methaemoglobin to haemoglobin. Scott' demonstrated in erythrocytes of Alaskan Eskimos and Indians that the patients were deficient in red cell NADH-diaphorase activity. Recently, reports have indicated that the major pathway of methaemoglobin reduction is associated with cytochrome b5 reductase and cytochrome b5,2 3 and hereditary methaemoglobinaemia has been attributed to the deficiency of cytochrome b5 reductase in erythrocytes.4 The sole clinical manifestation of this disease has been regarded as cyanosis.5 However, there have been several reports of methaemoglobinaemia associated with mental deficiency and neurological abnormalities.6 7 Kaplan and his associates established the relationship between a severe neurological ¶Present address: Department of Biochemistry, Medical
College of Oita, Hazama-cho, Oita 879-56, Japan. Received for publication 23 The proband, a 13-year-old Japanese boy was described by Nishina et 8 The activity of this enzyme was determined using cytochrome b5 as an electron acceptor, and it was virtually undetectable in the erythrocytes of both the patients (table 1) .
Electrophoresis of haemolysates from both the patients revealed a weak diaphorase band when concentrated and its mobility was the same as the usual major NADH-diaphorase. As cytochrome b5 reductase was undetectable in red cells from these patients, the residual reductase may be diaphorase I as defined by DEAE 
